Re:AlphaFold at CASP13: What just happened?
by throwawaylolx on Monday December 10, 2018 @06:49AM
(#18647179)
Sure, but I'd be surprised to see a pharmaceutical company profitably competing for talent with FAANG in the race of hiring top ML scientists.
Re:AlphaFold at CASP13: What just happened?
by dnautics on Monday December 10, 2018 @06:08AM
(#18646986)
Why should they invest in r&d when someone like alphabet will do it for them?
Re:AlphaFold at CASP13: What just happened?
by melling on Monday December 10, 2018 @06:40AM
(#18647128)
I believe they do spend a lot of money on R&D. Someone came along with a new idea and applied it to their field.
Now that Alphabet has sown them a better way, money should pour into the new technique.
Re:AlphaFold at CASP13: What just happened?
by dnautics on Monday December 10, 2018 @01:28PM
(#18650018)
While big pharma does do internal r&d, de facto, new drugs and drug strategies largely come by letting the government fund researchers (typically professors at large research institutes), encouraging these professors to do a spin-off (I deliberately don't want to use "startup") to absorb the scientific risk, followed by an acquisition for IP.
If they don't invest in R+D it's a choice.